The Clorox Company

NYSE:CLX

Household & Personal Products

Consumer Defensive
$108.39 -2.60%

-$2.54 today

Market cap
$13.13B
Beta
0.55
P/E (TTM)
15.2
EPS (TTM)
$6.23
Dividend yield
5.22%
52W Low $84.70High $132.03

Volume 2.16M

Average 2.84M

CLX Operating Income

Profit from core operations after operating expenses, before interest and taxes.

The Clorox CompanyNYSE: CLX

Operating Income · Q1 FY2027 · quarter ended Sep 2026

Operating income growth accelerates

Q1 FY2027 operating income of $451M rose 275.8% year over year, ahead of the +97.5% change in trailing-twelve-month operating income. Sequentially, it fell 55.9% from the prior quarter. Over 3 fiscal years it compounded at +26.4% a year.

Context

  • Operating income amounted to 24.7% of revenue in FY2026, up 8.2 pp from a year earlier.
  • Operating income increased in 2 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether operating income reaches the consensus estimate from 12 analysts of $1.08B (-35.0%) for the fiscal year ending Jun 2027, a slowdown from the +41.2% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$451M-55.9% QoQ
Last fiscal yearJun 2026
$1.66B+41.2% YoY
LTMSep 2026
$1.99B+97.5% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+275.8%-10.1%-285.9 pp
1 year+41.2%-35.0%-76.2 pp
3-year CAGR+26.4%-9.2%-35.6 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

USD · from the income statement

Latest · FY2026
1.66B USD
Year-over-year change
+41.2%
4-year CAGR
+23.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How CLX compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +97.5% is the 2nd highest of 11, against a peer median of -1.3%.
  • Operating income amounts to 27.7% of revenue for CLX, versus a peer median of 18.0%.
CLX Competitors
Operating Income for CLX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PGThe Procter & Gamble CompanyLTM Sep 2026$19.83B USD-3.3%+2.9%22.6%
ULUnilever PLCFY2025€9.04B EUR-3.9%-5.6%17.9%
CLColgate-Palmolive CompanyLTM Sep 2026$4.37B USD+0.6%-2.7%20.5%
KVUEKenvue Inc.LTM Sep 2026$3.09B USD+30.6%+0.4%19.9%
KMBKimberly-Clark CorporationLTM Jun 2026$2.05B USD-30.1%-2.4%12.4%
CLXThe Clorox CompanyLTM Sep 2026$1.99B USD+97.5%+26.4%27.7%
CHDChurch & Dwight Co., Inc.LTM Sep 2026$1.12B USD+5.3%+21.7%18.0%
REYNReynolds Consumer Products Inc.LTM Jun 2026$534M USD+4.3%+5.9%14.1%
SPBSpectrum Brands Holdings, Inc.LTM Jun 2026$238.8M USD+103.2%+75.3%8.3%
EPCEdgewell Personal Care CompanyLTM Mar 2026$62.7M USD-65.6%-19.1%3.0%
HELEHelen of Troy LimitedLTM Feb 2026-$702.91M USD-592.4%-20.4%39.3%
Peer median (excluding CLX) —-1.3%-1.0%18.0%

Competitors are the stored peer set for CLX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue7.11B7.39B7.09B7.1B6.72B
Cost of Revenue4.56B4.48B4.05B3.89B3.88B
Gross Profit2.55B2.91B3.05B3.21B2.84B
Gross Margin35.8%39.4%43.0%45.2%42.3%
Research & Development132M138M126M121M116M
Selling, General & Admin1.66B1.92B2.17B1.89B1.07B
Operating Expenses1.83B2.09B2.33B2.04B1.18B
Depreciation & Amortization224M236M235M219M247M
EBITDA937M564M723M1.39B1.17B
EBITDA Margin13.2%7.6%10.2%19.5%17.4%
Operating Income719M823M723M1.18B1.66B
Operating Margin10.1%11.1%10.2%16.6%24.7%
Interest Income5M16M23M9M8M
Interest Expense106M90M90M88M130M
Other Income / Expenses(112M)(585M)(325M)(99M)(871M)
Income Before Tax607M238M398M1.08B791M
Pre-Tax Margin8.5%3.2%5.6%15.2%11.8%
Income Tax Expense136M77M106M254M190M
Net Income462M149M280M810M587M
Net Margin6.5%2.0%3.9%11.4%8.7%
EPS (Basic)3.751.212.256.564.82
EPS (Diluted)3.731.202.256.524.81
Weighted Avg Shares123.11M123.59M124.17M123.53M121.78M
Weighted Avg Shares (Diluted)123.91M124.18M124.8M124.29M122.13M

The Clorox Company

NYSE:CLX

Intrinsic Alpha fair value

Locked

Current Price

$108.39

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.